Stay updated on Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page.

Latest updates to the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page
- Check2 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check9 days agoChange DetectedRemoved related topic links 'Melanoma' and 'MedlinePlus Genetics' from the page's related topics section.SummaryDifference0.1%

- Check17 days agoChange DetectedAdded Melanoma as a related topic and MedlinePlus Genetics as related topics on the study page.SummaryDifference0.1%

- Check24 days agoChange DetectedRemoved the melanoma keyword tag and the related topics MedlinePlus Genetics from the study page’s terms.SummaryDifference0.1%

- Check31 days agoChange DetectedRevision label updated to v3.5.0; the previous v3.4.3 label has been removed.SummaryDifference0.0%

- Check38 days agoChange DetectedMelanoma is now listed as a related topic, and MedlinePlus Genetics is added to related topics. The site revision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page.